eClinical Tech News

Cassava Sciences announced a 33% workforce reduction, cost-cutting measures, and anticipated topline data release from its Phase 3 REFOCUS-ALZ...

Micron Biomedical received a $7.5 million grant from the Bill & Melinda Gates Foundation, bringing total funding from the...

Solid Biosciences has received FDA clearance for its Investigational New Drug (IND) application for SGT-212, a gene therapy designed...

Sana Biotechnology announced positive initial results from a first-in-human study involving a patient with type 1 diabetes. The study,...

Cyclarity Therapeutics has received regulatory approval to commence its first-in-human clinical trial for UDP-003 at CMAX in Australia, partnered...

Biomea Fusion announced positive preclinical data for icovamenib combined with semaglutide, a GLP-1 receptor agonist, in treating type 2...

Carmell Corporation (Nasdaq: CTCX) recently closed a private placement, raising $1.85 million by issuing 8,065,210 shares of common stock...

Capricor Therapeutics has submitted a Biologics License Application (BLA) to the U.S. FDA for deramiocel, a cell therapy designed...

Neumora Therapeutics announced Phase 3 trial results for its major depressive disorder (MDD) drug, navacaprant. The KOASTAL-1 study, the...

Firefly Neuroscience (NASDAQ: AIFF) secured up to $12.4 million in financing, consisting of $2.4 million in convertible notes and...